We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 2,183

China intensifies pharmaceutical antitrust enforcement: NDRC rules in first-ever concerted practice case
  • AnJie Law Firm
  • China
  • October 13 2016

Since the Anti-monopoly Law's implementation in August 2008, antitrust authorities have mainly focused on industries that have a particular effect on

China to establish food and safety ‘blacklist’
  • Shook Hardy & Bacon LLP
  • USA, China
  • December 20 2013

The Chinese Food and Drug Administration (CFDA) has announced a public consultation on a draft regulation, "Provisions on the Administration of the

CFDA issues proposed regulations on medical devices
  • Covington & Burling LLP
  • China
  • April 9 2013

On March 20, 2013, the China Food and Drug Administration (CFDA) released for public comment two proposed regulations on medical devices. The first

Chinese Food and Drug Administration (CFDA) Proposes New Patent Linkage and Data Protection Regime
  • Spruson & Ferguson
  • China
  • May 18 2017

On 12 May, 2017 the CFDA published its intention to work on a new patent linkage and data protection system for China as part of a reform of its

Amended good supplying practice for pharmaceutical products
  • Cuatrecasas Gonçalves Pereira
  • China
  • May 31 2013

After three rounds of public consultation, MOH finally enacted the amended GSP standards, regulating all pharmaceutical distribution and introducing

Amended occupational disease diagnosis and assessment rules
  • Baker McKenzie
  • China
  • April 9 2013

The Ministry of Health issued the Amended Occupational Disease Diagnosis and Assessment Management Rules ("Amended Rules"), which took effect on

NHFPC solicits opinions on medical research measures
  • Grandall Law Firm
  • China
  • July 24 2013

The National Health and Family Planning Commission earlier this week began soliciting public opinion on the Measures for the Administration of

  • Global Law Office
  • China
  • July 18 2014


Global corporate insurance & regulatory bulletin
  • Mayer Brown JSM
  • China, European Union, United Kingdom, USA
  • December 5 2013

The China Insurance Regulatory Commission (“CIRC”) announced new rules (Implementing Rules of Provisional Measures on Outbound Investments with

Shanghai municipality released the provisional measures on the administration of wholly foreign owned medical institution in the China (Shanghai) Pilot Free Free Zone
  • King & Wood Mallesons
  • China
  • January 2 2014

On 13 November 2013, Shanghai Municipality released the Provisional Measures on the Administration of Wholly Foreign-Owned Medical Institutions in